Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention

Angiology. 2014 Jan;65(1):37-42. doi: 10.1177/0003319712463816. Epub 2012 Oct 29.

Abstract

We assessed the relationship between contrast-induced nephropathy (CIN) and SYNTAX score (SS) and serum uric acid (SUA) levels in patients with ST elevation myocardial infarction (STEMI). A total of 835 STEMI patients in whom primary percutaneous coronary intervention was performed in our cardiology clinic were included in this study (615 male, 220 female; mean age 58.1 ± 12.2 years). The patients were divided into 2 groups (CIN and non-CIN). Contrast-induced nephropathy was observed in 9.6% (80) of patients; SS (13.9 ± 6.2/22.1 ± 5.8) and SUA (5.1 ± 0.9/6.2 ± 0.9) values in the CIN group were higher compared with the non-CIN group (P < .001, for all). All SS (95% confidence interval [CI] = 1.136-1.250, P = .001), SUA (95% CI = 1.877-3.236, P = .002), and diabetes (95% CI = 0.998-1.039, P = .026) were independent predictors of CIN in logistic regression analysis. Procedures that can prevent CIN may be beneficial in patients at high risk as identified by the SS and SUA levels.

Keywords: SYNTAX score; contrast media; myocardial infarction; nephropathy; uric acid.

MeSH terms

  • Adult
  • Aged
  • Contrast Media / adverse effects*
  • Coronary Angiography / adverse effects*
  • Female
  • Humans
  • Kidney Diseases / blood
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / diagnostic imaging
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / diagnostic imaging*
  • Myocardial Infarction / therapy
  • Percutaneous Coronary Intervention / adverse effects*
  • Prevalence
  • Uric Acid / blood*

Substances

  • Contrast Media
  • Uric Acid